Alpha 2.0
Login Register
» Authors » C Kentenich

C Kentenich

Explore the profile of C Kentenich including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 178
Followers 0
Related Specialties
Oncology
General Medicine
Top 10 Co-Authors
W Janni
F Hepp
S Braun
H Sommer
C Schindlbeck
D Rjosk
K Pantel
B Strobl
B Rack
P Hantschmann
Published In
J Clin Oncol
Cancer
Acta Med Austriaca Suppl
Oncology
Dtsch Med Wochenschr
Affiliations
Soon will be listed here.
Recent Articles
1.
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer
Stemmler J, Mair W, Stauch M, Papke J, Deutsch G, Abenhardt W, et al.
Oncology . 2005 Apr; 68(1):71-8. PMID: 15809523
Background: Docetaxel is one of the most effective antitumor agents currently available for the treatment of metastatic breast cancer (MBC). This phase II multicenter study prospectively analyzed the efficacy and...
2.
[Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer]
Rack B, Janni W, Kentenich C, Strobl B, Klanner E, Schindlbeck C, et al.
Acta Med Austriaca Suppl . 2003 Jan; 59:36-41. PMID: 12506759
The clinical course of cervical carcinoma is widely determined by locoregional recurrence. There is increasing data, however, that haematogenic micrometastases occur early during the disease and might result in distant...
3.
[The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer]
Janni W, Strobl B, Rack B, Rjosk D, Schindlbeck C, Hantschmann P, et al.
Dtsch Med Wochenschr . 2002 Jan; 127(3):71-7. PMID: 11797143
Background And Objective: In the last few years special attention has been paid to the serum concentration of haemoglobin in patients with cancer. It was the aim of this study...
4.
The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence
Janni W, Hepp F, Rjosk D, Kentenich C, Strobl B, Schindlbeck C, et al.
Cancer . 2001 Jul; 92(1):46-53. PMID: 11443608
Background: The current study examines the fate of occult metastatic cells detected in bone marrow (BM) at primary diagnosis and evaluates whether persistently positive findings support the prognostic influence of...
5.
Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse
Braun S, Schindlbeck C, Hepp F, Janni W, Kentenich C, Riethmuller G, et al.
J Clin Oncol . 2001 Feb; 19(2):368-75. PMID: 11208828
Purpose: Based on conventional tumor staging, primary ovarian cancer is viewed as an intraperitoneal disease that rarely spreads to extraperitoneal organs. However, autopsy studies reveal a much higher rate of...
6.
Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma
Janni W, Gastroph S, Hepp F, Kentenich C, Rjosk D, Schindlbeck C, et al.
Cancer . 2000 May; 88(10):2252-9. PMID: 10820346
Background: Using cytokeratin (CK) as a histogenetic marker of epithelial tumor cells in the bone marrow of patients with primary breast carcinoma, a subgroup of patients with decreased survival can...
7.
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
Braun S, Kentenich C, Janni W, Hepp F, de Waal J, Willgeroth F, et al.
J Clin Oncol . 2000 Jan; 18(1):80-6. PMID: 10623696
Purpose: There is an urgent need for markers that can predict the efficacy of adjuvant chemotherapy in patients with solid tumors. This study was designed to evaluate whether monitoring of...